News Releases

A New Strategy for Making Blood Stem Cells Healthier
Two Prominent Researchers Take Helm of Psychiatric Research Institute at Montefiore Einstein
Two Nature Papers Highlight an Understudied Protein

Facts & Stats

Published Papers
NIH Research Funding
Full-time Faculty
Global Initiatives
Clinical and Research Centers

Expert List for Media

Jeffrey E. Pessin

Jeffrey E. Pessin, Ph.D.

Area(s) of expertise: DiabetesType 1 diabetesMetabolism

Dr. Pessin directs the Einstein-Mount Sinai Diabetes Research Center, one of only sixteen NIH-funded diabetes centers of its kind in the country. He guides the research of more than 90 scientists investigating type… Learn more

Einstein in the News

NYC Invests $38M into New Biotech Centers

Montefiore and Einstein will receive $13 million from New York City as part of its investment in new biotech centers. The Einstein-Montefiore Biotechnology Accelerated Research Center (EMBARC) will establish a biomanufacturing operation focused on cell, gene, and antibody therapy production and will provide scientific facilities to early-stage and established companies.

Additional Coverage includes AMNY, New York Business Journal, Connect New York,, Yahoo News, and WPIX11

The Scientist
What's Ahead for SARS-CoV-2 Research in 2021

Kartik Chandran, Ph.D., talks about the future of COVID-19 research, including the development of treatments and vaccines to treat and prevent the novel coronavirus as it mutates over time. Dr. Chandran is professor of microbiology & immunology and the Harold and Muriel Block Scholar in Virology at Einstein.

More coverage on Dr. Chandran

The New York Times
Blood Plasma Reduces Risk of Severe Covid-19 if Given Early

Liise-anne Pirofski, M.D., discusses a small Argentinian clinical trial that found convalescent plasma was effective in reducing the risk of severe COVID-19 in older patients if they received the treatment within three days of showing symptoms. Dr. Pirofski is chief of infectious diseases at Einstein and Montefiore.

More coverage on Dr. Pirofski


When a Drug Becomes a Child’s Last Hope

Einstein scientist Vern Schramm, Ph.D., never imagined that his basic research into enzymes would intersect with a 2-year-old girl dying from an incurable form of blood cancer. He and that girl (Katie Lambertson, now a teenager) and her parents share their stories.

Watch more videos

The Doctor's Tablet Blog